Evaluation of Sofosbuvir and Daclatasvir Combo in COIVD-19 Patients in Egypt
NCT04773756
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
54
Enrollment
OTHER
Sponsor class
Conditions
Covid19
Interventions
DRUG:
Sofosbuvir 400 MG/ Daclatasvir 60mg
Sponsor
Alexandria University